Soyfoods: Part of a Comprehensive Approach to Lowering Chronic Disease Risk

A systematic review and meta-analysis published by Canadian researchers highlights the important role plant protein, and in particular soy protein, can have in reducing risk of cardiovascular disease (CVD). It also indirectly highlights the comprehensive dietary approach required to markedly reduced CVD risk.

The meta-analysis, which included 112 clinical trials, found that replacing animal protein with plant protein decreased LDL-cholesterol by a statistically significant 0.16 mmol/L, which worked out to be about a four percent reduction. The median protein substitution was ~30 g/d. The trials ranged in duration from three weeks to four years, with a median follow up of six weeks. Importantly, of the 112 trials included in the analysis, 94 used soy protein as the sole plant protein and 74 used dairy as the sole animal protein intervention.

To read the rest of this story, originally posted from the Soy Nutrition Institute, click here.

Click here to continue reading this article.

Disclaimer: The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the policy or position of U.S. Soy.
Mark Messina, Ph.D.
Mark Messina, Ph.D.

Executive Director

Soy Nutrition Institute

Dr. Mark Messina is a nationally recognized expert on the health effects of soy.